It’s another up-and-down day as investors try to weigh what seems to be a strong U.S. economy and weakening global economy. This of course, makes it tough to bid up stocks to new highs, but at the same time, it’s hard to sell U.S. equities when it’s the best house in the neighb
This article is about Domino’s Pizza (DPZ) and why it's a great buy for the total return investor that also wants some dividend income. Domino’s Pizza is one of the largest fast food companies in the United States and foreign countries.
This week, Delta Air Lines (DAL) announced plans to expand in Boston, perhaps doing to JetBlue Airways (JBLU) what it did to Alaska Air (ALK) in Seattle. Wolfe Research’s Hunter Keay and Matt Morris consider the implications:
Eric Thayer/Getty Images
On Monday,Delta issued a lengthy press release detailing its desire to grow in Boston. The release didnt emphasize the growth....More>>>
Tax audits are in the news more than usual this year, since Donald Trump says the fact that hes being audited by the IRS prevents him from releasing his returns as part of his quest for the presidency.
TOOL: Pinpoint Your Audit Odds
But if being audited blocked the release of a tax return, we never would have seen Barack Obamas or George W. Bushs or Bill Clintons or any other recent....More>>>
Just over three months after the authorities lifted the four-decade ban on crude oil exports, the U.S. has actually exported less this year than it did over the same period the year before, when the ban was still in place.
According to Clipper Data market intelligence cited by the Financial Times, we’ve seen a 5 percent decline in U.S. crude oil export....More>>>
Today, central banks are acting more aggressively than ever before to stave off deflation and spur global growth. The European Central Bank, the People’s Bank of China, the Bank of Japan, the Bank of England and the Federal Reserve have all embarked on quantitative easing (QE) programs following the 2008 financial crisis.
See Also: Kiplinger’s Economic Outlook on Interest Rates....More>>>
American Express (AXP) is stuck between a rock and a hard place. As it battles MasterCard (MA) and Visa (V), American Express can either try to match their rewards–which will damage its returns–or stand its ground, which will make it hard to compete. Evercore ISI’s David Togut and team explain:
Credit card rewards continue to spiral skywards asAmerican....More>>>
Leerink’s Geoffrey Porges and Assaf Vestin are attending the annual American Society of Clinical Oncology, or ASCO, meeting and came away seeing the “biggest positive impact” forCelgene (CELG), but only a “modest” impact for Amgen (AMGN),Regeneron Pharmaceuticals (REGN) and Gilead Sciences (GILD). They explain:
BMO Capital Markets analyst M. IanSomaiya and team take a look at the “clinical readouts through the end of 2016″ and find upside catalysts for Celgene (CELG), Amgen (AMGN), Biogen (BIIB), and Gilead Sciences (GILD) They explain:
Paulo Fridman/Bloomberg News
Celgene: We believe positive data from the mongersen Phase 2 endoscopy study should move shares higher if....More>>>
A steady stream of multi-factor exchange traded funds have been coming to market for over a year now. Multi-factor ETFs offer investors exposure to several investment factors – the idea being that investors don't need to time when a certain factor will perform well and when others will fall out of favor.
The Global X Scientific Beta US ETF (NYSE: SCIU), which is 14 months old,....More>>>
Related HPQ Should Investors Shift Away From 'Old Tech' Legacy Stocks Into Cloud-Based Platforms? Will Investors Care If HP Cuts Guidance? After Hours: HP Spinoff To Spin Off; Bayer Upbeat On Monsanto (Investor’s Business Daily) Related TIF Nomura Previews Tiffany's Q1 Earnings: 'The Value....More>>>
The coffee market is back in the news, but the latest development may not have a big impact 0n Starbucks (NASDAQ:SBUX), stock. Burger King recently announced a $5 per month coffee subscription model, giving members one free cup of coffee per day.
On Thursday, shares of Biogen (NASDAQ:BIIB) were hammered, falling more than 29% in just one session. Biogen stock was again under pressure on Friday, falling almost 3% on the day. The move puts the stock down massively on the week and below key support.